Psychedelics and Parkinson’s may trigger hallucinations through the same system, revealing how fragile the balance is between externally and internally generated perception.

A new systematic review led by University of Melbourne researchers finds psilocybin reduces obsessive and compulsive symptoms ...

Researchers at the University of the Balearic Islands report that orally administered psilocybin produced rapid and durable ...

HealthDay News — Chronic traumatic encephalopathy (CTE) is more common in people who experience extensive repetitive head impacts (RHI), according to a study published online Oct. 18 in the Journal of ...

Texas is set to launch a $50 million ibogaine research study after new Stanford findings showed major PTSD and TBI ...

Compass Pathways, which is developing a psilocybin treatment for severe depression, said it now expects an earlier decision ...

Drug developer Compass Pathways said on Tuesday it is pulling forward the expected launch timing of its experimental psilocybin-based depression therapy by 9 to 12 months.

Research suggests psilocybin may ease obsessive-compulsive behaviors, offering fast, lasting relief after a single dose.

Out Nov. 3, In Waves and War focuses on a group of U.S. Navy SEALS who take Ibogaine, derived from a shrub native to Central ...

Suicide is a tragic epidemic among US military veterans, but a new documentary charts how psychedelic drugs offer a glimmer ...

Researchers are testing psilocybin therapy to ease fear, anxiety, and depression in people with advanced cancer.

Micah Parsons briefly exited the Green Bay Packers-Dallas Cowboys game to treat an injury but he later returned. The Packers' star defensive end left the game against the Cowboys on Sunday night in ...